<DOC>
	<DOC>NCT01375387</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of lacosamide following single oral administration of lacosamide 100 mg, 200 mg and 400 mg in healthy male Chinese and Japanese subjects.</brief_summary>
	<brief_title>Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Healthy Chinese or Japanese volunteers Subject has participated or is participating in any other clinical studies of Lacosamide within the last 3 months Subject is not healthy (eg, taking any drug treatments, excessive amount of alcohol, cigarettes or caffeine, having any psychological or emotional problems, a drug/alcohol abuse, abnormal diet, having abnormal safety parameters)</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Vimpat</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy Japanese male</keyword>
	<keyword>Healthy Chinese male</keyword>
</DOC>